摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

bis[4-oxo-3-phenyl-1(H)-2-thioxothieno(3,2-d)pyrimidine] | 330855-84-0

中文名称
——
中文别名
——
英文名称
bis[4-oxo-3-phenyl-1(H)-2-thioxothieno(3,2-d)pyrimidine]
英文别名
5,13-Diphenyl-4,14-bis(sulfanylidene)-8,10-dithia-3,5,13,15-tetrazatetracyclo[7.7.0.02,7.011,16]hexadeca-1(9),2(7),11(16)-triene-6,12-dione
bis[4-oxo-3-phenyl-1(H)-2-thioxothieno(3,2-d)pyrimidine]化学式
CAS
330855-84-0
化学式
C22H12N4O2S4
mdl
——
分子量
492.627
InChiKey
DNPSUISCUCBUIK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.3
  • 重原子数:
    32
  • 可旋转键数:
    2
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    185
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    bis[4-oxo-3-phenyl-1(H)-2-thioxothieno(3,2-d)pyrimidine]吡啶氢氧化钾一水合肼 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 14.0h, 生成 8,16-diphenyl-4,20-bis(sulfanylidene)-11,13-dithia-3,5,6,8,16,18,19,21-octazahexacyclo[10.10.0.02,10.03,7.014,22.017,21]docosa-1(12),2(10),6,14(22),17-pentaene-9,15-dione
    参考文献:
    名称:
    多稠合噻吩并 (2,3-b) 噻吩的合成第 3 部分:噻吩并嘧啶并四唑、噻吩并嘧啶并三氮杂、噻吩并嘧啶并三嗪、噻吩并嘧啶并三唑和吡唑并噻吩并嘧啶衍生物的合成
    摘要:
    2,9-二肼基双嘧啶(2,3-b)噻吩并噻吩 (2) 与亚硝酸、乙氧基亚甲基丙二腈、溴丙二腈、甲酸三乙酯、CS 2 或靛红反应,分别得到相应的四唑、三氮杂、三嗪和三唑衍生物 3-8 . 用环己叉腈、乙酰丙酮、乙酰乙酸乙酯、2-羟基苯乙酮或S,S-缩醛处理化合物2分别得到相应的吡唑衍生物9-15。
    DOI:
    10.1080/10426500307790
  • 作为产物:
    参考文献:
    名称:
    SYNTHESIS OF POLYFUSED THIEN0(2,3-b)THIOPHENES PART 2: SYNTHESIS OF THIENOPYRIMIDINE, THIENOTHIAZINE, THIENOPYRROLOPIPRAZINE, AND THIENOTHIAZAPHOSPHOLINE DERIVATIVES
    摘要:
    3,4-Diamino-2,5-dicarbethoxythieno(2,3-(b) under bar )thiophene (1) was reacted with triethylorthoformate to afford compound 2. The reaction of compounds 2 or 3 with S.S-acetals and N,S-acetals, afforded compounds 4-6. Treatment of compound 1 with 2,5 -dimethoxytetrahydrofuran gave the corresponding bipyrrolyl derivative 7, which was reacted with hydrazine hydrate to get the corresponding hydrazide derivative 8. Treating compound 8 with sodium nitrite afforded the corresponding carboazide derivative 9, which in rum cyclized to compound 10. Compound 12 was obtained via the reaction of compound 1 with PhNCS or through treating compound 11 with CS2 PhNH2, and KOH. Also, compound 13 was prepared through treatment of compound 12 wi;h Lawesson's reagent or via the reaction of compound 11 with CS2 followed by treating the resulting compound 14 with PhNH2. The reaction of compounds 1 or 3 with Lawesson's reagent gave compound 15. Benzoylation of compound 1 afforded compound 16, which treated with NH3 gave compound 17. Treatment of compounds 16 or 17 with LR furnished compounds 18 or 19, respectively. The reaction of compound 16 or 17 with P2S5 yielded compounds 19 and 20 or 18 and 19, respectively.
    DOI:
    10.1080/10426500008076530
点击查看最新优质反应信息

文献信息

  • Synthesis of Polyfused Thieno(2,3- b )thiophenes Part 3: Synthesis of Thienopyrimidinotetrazole, Thienopyrimidinotriazepine, Thienopyrimidinotriazine, Thienopyrimidinotriazole and Pyrazolylthienopyrimidine Derivatives
    作者:A. Khodairy
    DOI:10.1080/10426500307790
    日期:2003.4
    2,9-Dihydrazinobipyrimidino(2,3- b )thienothiophene ( 2 ) was reacted with nitrous acid, ethoxymethylenemalononitrile, bromomalononitrile, triethyl formate, CS 2 or isatine to afford the corresponding tetrazole, triazepine, triazine, and triazole derivatives 3-8 respectively. Treatment of compound 2 with cyclohexylidenenitriles, acetylacetone, ethyl acetoacetate, 2-hydroxyacetophenone, or S,S-acetals
    2,9-二肼基双嘧啶(2,3-b)噻吩并噻吩 (2) 与亚硝酸、乙氧基亚甲基丙二腈、溴丙二腈、甲酸三乙酯、CS 2 或靛红反应,分别得到相应的四唑、三氮杂、三嗪和三唑衍生物 3-8 . 用环己叉腈、乙酰丙酮、乙酰乙酸乙酯、2-羟基苯乙酮或S,S-缩醛处理化合物2分别得到相应的吡唑衍生物9-15。
  • SYNTHESIS OF POLYFUSED THIEN0(2,3-<u>b</u>)THIOPHENES PART 2: SYNTHESIS OF THIENOPYRIMIDINE, THIENOTHIAZINE, THIENOPYRROLOPIPRAZINE, AND THIENOTHIAZAPHOSPHOLINE DERIVATIVES
    作者:H. Abdel-ghany、A. Khodairy
    DOI:10.1080/10426500008076530
    日期:2000.1.1
    3,4-Diamino-2,5-dicarbethoxythieno(2,3-(b) under bar )thiophene (1) was reacted with triethylorthoformate to afford compound 2. The reaction of compounds 2 or 3 with S.S-acetals and N,S-acetals, afforded compounds 4-6. Treatment of compound 1 with 2,5 -dimethoxytetrahydrofuran gave the corresponding bipyrrolyl derivative 7, which was reacted with hydrazine hydrate to get the corresponding hydrazide derivative 8. Treating compound 8 with sodium nitrite afforded the corresponding carboazide derivative 9, which in rum cyclized to compound 10. Compound 12 was obtained via the reaction of compound 1 with PhNCS or through treating compound 11 with CS2 PhNH2, and KOH. Also, compound 13 was prepared through treatment of compound 12 wi;h Lawesson's reagent or via the reaction of compound 11 with CS2 followed by treating the resulting compound 14 with PhNH2. The reaction of compounds 1 or 3 with Lawesson's reagent gave compound 15. Benzoylation of compound 1 afforded compound 16, which treated with NH3 gave compound 17. Treatment of compounds 16 or 17 with LR furnished compounds 18 or 19, respectively. The reaction of compound 16 or 17 with P2S5 yielded compounds 19 and 20 or 18 and 19, respectively.
查看更多

同类化合物

林扎戈利 替普司特 噻吩并[3,4-d]嘧啶-2,4(1H,3H,5H,7H)-二酮 噻吩并[3,2-d]嘧啶-7-甲胺 噻吩并[3,2-d]嘧啶-4-羧酸 噻吩并[3,2-d]嘧啶-4(1H)-硫酮 噻吩并[3,2-d]嘧啶,4-(甲硫基)- 噻吩并[3,2-d]嘧啶 噻吩并[3,2-D]嘧啶-7-羧酸 噻吩并[3,2-D]嘧啶-7-甲醛 噻吩并[3,2-D]嘧啶-7-基甲醇 噻吩并[3,2-D]嘧啶-2-胺 噻吩并[2,3-d]嘧啶-4-胺 噻吩并[2,3-d]嘧啶-4-硫醇 噻吩并[2,3-d]嘧啶-4(3H)-酮 噻吩并[2,3-d]嘧啶-2,4-二胺 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(3-甲氧苯基)-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(3-氯苯基)-1-[(2,6-二氟苯基)甲基]-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(2-氯苯基)-1-[(2,6-二氟苯基)甲基]-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶 噻吩并[2,3-D]嘧啶-6-羧酸 噻吩并[2,3-D]嘧啶-6-甲醛 吡啶并[3’,2’:4,5]噻吩并[3,2-d]嘧啶-4(3h)-酮 乙基3-甲基-5-羰基-5H-[1]苯并噻吩并[2,3-d][1,3]噻唑并[3,2-a]嘧啶-2-羧酸酯 乙基2-(4-氯苯基)-7-甲基-9-羰基-9H-[1,3]噻唑并[3,2-a]噻吩并[3,2-d]嘧啶-6-羧酸酯 {[((4-氧代-3,4,5,6,7,8-六氢[1]苯并噻吩并[2,3-d]嘧啶-2-基)甲基]硫基}乙酸 [(6-甲基噻吩并[2,3-d]嘧啶-4-基)硫基]乙酸 [(4-氧代-3,4,5,6,7,8-六氢[1]苯并噻吩并[2,3-d]嘧啶-2-基)硫基]乙酸 PI3K抑制剂 PF-3758309抑制剂 Necrostatin-5; 2-[[3,4,5,6,7,8-六氢-3-(4-甲氧基苯基)-4-氧代[1]苯并噻吩并[2,3-d]嘧啶-2-基]硫代]-乙腈 N-甲基-1-噻吩并[3,2-d]嘧啶-4-基-4-哌啶甲胺 N-[2-[[3,4-二氢-4-氧代-3-[4-(2,2,2-三氟乙氧基)苯基]噻吩并[3,4-d]嘧啶-2-基]硫基]乙基]乙酰胺 N-[(1S)-2-(二甲基氨基)-1-苯基乙基]-2,6-二氢-6,6-二甲基-3-[(2-甲基噻吩并[3,2-d]嘧啶-4-基)氨基]-吡咯并[3,4-c]吡唑-5(4H)-甲酰胺盐酸盐 N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-3-(2-甲氧基苯基)-4-氧噻吩并[3,2-d]嘧啶-2-基)硫代]-乙酰胺 N-(4-氟苯基)-5,6-二甲基噻吩并[2,3-D]嘧啶-4-胺 N-(4-吗啉-4-基噻吩并[2,3-e]嘧啶-2-基)乙烷-1,2-二胺 N,N-二甲基-5,6,7,8-四氢苯并[4,5]噻吩并[2,3-D]嘧啶-4-胺 IWP2;N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-4-氧代-3-苯基噻吩并[3,2d]嘧啶-2-基)硫基]乙酰胺 AR-C 155858; (S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基]-5-[(4-羟基异噁唑烷-2-基)羰基]-1-异丁基-3-甲基噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮 7-甲基噻吩并[3,2-D]嘧啶-4-胺 7-甲基-噻吩并[3,2-d]嘧啶-2,4(1h,3h)-二酮 7-甲基-噻吩并[3,2-d]嘧啶 7-甲基-5,6,7,8-四氢[1]苯并噻吩并[2,3-d]嘧啶-4(3h)-酮 7-甲基-5,6,7,8-四氢-苯并[4,5]噻吩并[2,3-d]嘧啶-4-硫醇 7-溴噻吩并[3,2-d]嘧啶 7-溴噻吩并[3,2-D]嘧啶-4(1H)-酮 7-溴-噻吩并[3,2-d]嘧啶-4-胺 7-溴-4-氯噻酚并[3,2-D]嘧啶 7-溴-2-氯噻吩并[3,2-D]嘧啶